Company
McKesson Corporation
Headquarters: Irving, TX, United States
Founded: New York City, United States1833
Employees: 59,000
CEO: Mr. Brian S. Tyler Ph.D.
Market Cap
$75.67 Billion
USD as of July 1, 2024
McKesson Corporation Categories
United States Healthcare Medical DistributionUnited States Healthcare United States Medical Distribution
Top Competitors by Market Capitalization
Industry: Medical Distribution
| Company | Market Cap (USD) |
|---|---|
| Cencora, Inc. | $43.82 B |
| Cardinal Health, Inc. | $23.31 B |
| Shanghai Pharmaceuticals Holding Co. Ltd | $8.79 B |
| Sinopharm Group Co. Ltd | $8.37 B |
| Henry Schein, Inc. | $8.32 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Detailed Description
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Stocks & Indices
McKesson Corporation has the following listings and related stock indices.
Stock: NYSE: MCK wb_incandescent
Stock: BMV: MCK wb_incandescent
Stock: Bovespa: M1CK34 wb_incandescent
Stock: FSX: MCK wb_incandescent
Product & Services
PharmaceuticalsMedical technologyHealth care services
Key People
Founder(s): John Mc Kesson Charles Olcott
Brian S. Tyler (CEO)
Financials
Revenue: US$231.051 billion (2020): 35
Operating income: US$1.120 billion (2020): 35
Net income: US$1.126 billion (2020): 35
Total assets: US$61.247 billion (2020): 35
Total equity: US$5.092 billion (2020): 35